Skip to content
OpenCapital
Get started

Immunome IMNM Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%
Nuvation Bio logo
Nuvation BioNUVB
$1.49B+150%
SELLAS Life Sciences Group, Inc. logo
SELLAS Life Sciences Group, Inc.SLS
$759.63M+674%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$2.93B+104%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%

Other financials

Income statement

See full
Revenue--100%
Operating income-$59.3M-32.9%
Net income-$53.8M-29.3%
EPS (diluted)-$0.48+7.7%

Balance sheet

See full
Cash & equivalents$582.7M+126%
Total debt$3.7M-22.6%
Total equity$588.7M+91.7%
Total assets$619.8M+80.9%

Cash flow

See full
Operating cash flow-$58.6M-10.5%
CapEx$3.0M-18.1%
Free cash flow-$61.6M-8.7%

Valuation

See full
Enterprise value$1.61B+470%
P/S545.2×+498×

Profitability

See full
Operating margin-5,947.9%-12,002pp
Net margin-5,593.8%-11,284pp
FCF margin-5,118.9%-8,601pp

Returns & leverage

See full
Return on equity-50.1%-10.8pp
Debt / equity0×0.0×
Current ratio21.7×+11.2×

Where this comes from

Computed from the period-end share price: $2.47B.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunome's market capitalization?
Immunome (IMNM) reported market capitalization of $2.47B in Q1 2026.
How has Immunome's market capitalization changed year-over-year?
Immunome's market capitalization increased by 322.8% year-over-year, from $585.18M to $2.47B.
What is the long-term trend for Immunome's market capitalization?
Over 5 years (2020 to 2025), Immunome's market capitalization has grown at a 82.5% compound annual growth rate (CAGR), from $117.13M to $2.37B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.